Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
476
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Celltrion Inc
•
28 Feb 2018 05:51
Celltrion's Mar 8 KOSPI 200 Inclusion Event Update
It is now really time to be serious about Celltrion's KOSPI 200 inclusion event on Mar 8. We have about one week of time, which means some of us...
Sanghyun Park
Follow
342 Views
Share
bearish
•
Celltrion Inc
•
15 Feb 2018 23:24
Biosimilar Battlefield: An Update
Korea's biosimilar plays, Celltrion Inc (068270 KS) , Celltrion Pharm Inc (068760 KS) , Celltrion Healthcare (091990 KS) , and Samsung Biologics...
Kemp Dolliver, CFA
423 Views
Share
bullish
•
Fast Retailing
•
11 Feb 2018 09:36
Last Week in Event SPACE - Fast Retailing, Hyundai Heavy, Japan Display, Qualcomm, Intouch
Last week, Fast Retailing Co Ltd (9983 JP) may be materially impacted should the BOJ revamp its purchase programs; a decent arb return in Hyundai...
David Blennerhassett
Follow
311 Views
Share
bullish
•
Celltrion Inc
•
09 Feb 2018 06:22
KOSDAQ 150 Rebalancing & Celltrion Short Selling During Feb 7-8
The KRX officially said on Feb 7 that Celltrion Inc (068270 KS) would be listed on the KOSPI on Feb 9. This means there would be a massive index...
Sanghyun Park
Follow
313 Views
Share
bullish
•
Celltrion Inc
•
04 Feb 2018 00:10
Last Week in Event SPACE - Astellas, Celltrion, Renesas, AWE, Viva, Kushikatsu
Last week, Astellas Pharma Inc (4503 JP)'s latest buyback may impact the stock; KOSDAQ 150 names expected to benefit as Celltrion Inc (068270 KS)...
David Blennerhassett
Follow
204 Views
Share
First
Previous
73
74
75
76
77
78
79
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x